State Health Policy Blog

The Graham-Cassidy amendment represented a radical overhaul of how health care coverage is financed and delivered, raising anew the question of federalism – what should the federal government guarantee and how much state variation should be supported? The legislation tossed most critical health care coverage and policy decisions to states without giving them sufficient time or […]

Read More
  • State Health Policy Blog

    The Centers for Medicare & Medicaid Services (CMS) recently released its third annual evaluation of the State Innovation Model (SIM) Round One Test States, which analyzes the ability of states to use policy and regulatory levers to drive statewide health care transformation. The evaluation, completed by a team of researchers from RTI International, the Urban […]

    Read More
    September 26, 2017 | Filed under: Blog Posts, Front Page, Maine, Minnesota, State Health Policy Blog, Vermont
  • State Medicaid Agencies Venture into Value-Based Purchasing with Federally Qualified Health Centers
    State Health Policy Blog

    State Medicaid agencies have generally found it challenging to include federally qualified health centers (FQHCs) in value-based purchasing initiatives because of a federal law passed in 2000 that regulates how state Medicaid programs pay FQHCs for the care they provide. State Medicaid agencies are required to reimburse FQHCs through the Prospective Payment System (PPS), a […]

    Read More
  • State Health Policy Blog

    Time is running out for Congress to reform the nation’s health care system, and the Senate is considering two options that could impact state health care policies dramatically. The choices include a bipartisan bill to stabilize the Affordable Care Act’s (ACA) insurance markets and give states the information they need to set insurance rates for […]

    Read More
  • CHIP’s Future: There Are Hopeful Signs from Congress, But States Still Face Uncertainty
    State Health Policy Blog

    With less than two weeks to go before current federal funding for the Children’s Health Insurance Program (CHIP) ends, Sens. Orrin Hatch and Ron Wyden have introduced a bipartisan bill to extend the program for five years. However, state officials face the unsettling possibility that if Congress is unable to pass this legislation and appropriate […]

    Read More
    September 19, 2017 | Filed under: Blog Posts, Children's Health, Front Page, State Health Policy Blog
  • State Health Policy Blog

    States have a long history of using home visiting programs to deliver cost-effective interventions to vulnerable children and families, and recent federal investments have been instrumental in the expansion of evidence-based home visiting programs across the United States. Due to budget uncertainties at the state and federal level, states are exploring opportunities to maximize investments […]

    Read More
  • State Health Policy Blog

    This month, the Senate Health Education and Labor (HELP) committee began to craft a bipartisan bill to bring short-term stability to the Affordable Care Act’s (ACA) individual insurance market. The committee, led by Chairman Lamar Alexander (R-TN) and ranking member Patty Murray (D-WA), hosted a series of four hearings featuring insurance commissioners, consumer advocates, a […]

    Read More
  • State Health Policy Blog

    As Congress returns from its summer break, the country is two months away from the start of open enrollment in the Affordable Care Act’s (ACA) marketplace, leaving little time for policymakers to develop solutions for 2018. With bipartisan hearings on market stabilization scheduled, this blog examines how different approaches to calculating risk could help state […]

    Read More
  • State Health Policy Blog

    We are five weeks away from September 30th, the date current federal funding for the Children’s Health Insurance Program (CHIP) is set to end. Although states can use some of the unspent federal funds that were previously allocated to them, it is projected that those funds will be exhausted during the next fiscal year, beginning […]

    Read More
  • Lowering Drug Costs: Transparency Legislation Sets Off Flurry of New State Approaches
    State Health Policy Blog

    Responding to rapidly rising drug costs, 30 states across the country have drafted more than 60 drug price transparency bills designed to: Identify the costs that contribute to drug manufacturer expenses and list prices And unveil the often opaque business practices of pharmacy benefit managers (PBMs). In addition to promoting pricing transparency, as of early […]

    Read More